{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:12:05Z","timestamp":1793351525487,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clinthera.2017.12.008","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T13:08:32Z","timestamp":1515244112000},"page":"1442-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"Catherine J.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Galettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Solowij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.12.008_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40262-015-0363-2","article-title":"Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome","volume":"55","author":"Reuter","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.12.008_bib2","first-page":"21","article-title":"Development of a simple LCMSMS method for THC and metabolites in plasma","volume":"12","author":"Galettis","year":"2016","journal-title":"Asia-Pacific J Clin Oncol"},{"key":"10.1016\/j.clinthera.2017.12.008_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1373\/clinchem.2012.194381","article-title":"Cannabis effects on driving skills","volume":"59","author":"Hartman","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2017.12.008_bib4","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.clinthera.2017.12.008_bib5","year":"2012","journal-title":"Notification of the GRAS Determination of Medium Chain Triglycerides When Added Directly to Human Food"},{"key":"10.1016\/j.clinthera.2017.12.008_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.dld.2015.03.009","article-title":"Prospective evaluation of the aetiological profile of acute pancreatitis in young adult patients","volume":"47","author":"Culetto","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinthera.2017.12.008_bib7","first-page":"137","article-title":"Cannabinoids in acute gastric damage and pancreatitis","volume":"57","author":"Dembinski","year":"2006","journal-title":"J Physiol Pharmacol"},{"issue":"131","key":"10.1016\/j.clinthera.2017.12.008_bib8","first-page":"e3","article-title":"Cannabis-induced acute pancreatitis","volume":"29","author":"Belze","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clinthera.2017.12.008_bib9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1476-5381.2009.00399.x","article-title":"Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure","volume":"158","author":"Gunasekaran","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2017.12.008_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3565(25)32251-2","article-title":"Tolerance and disposition of tetrahydrocannabinol in man","volume":"215","author":"Hunt","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2017.12.008_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.clinthera.2017.12.008_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.12.008_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-014-0195-5","article-title":"Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics","volume":"54","author":"Heuberger","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.12.008_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinthera.2017.12.008_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00002480-198904000-00002","article-title":"Absorption of fluid and solutes from the peritoneal cavity: theoretic and therapeutic implications and applications","volume":"35","author":"Mactier","year":"1989","journal-title":"ASAIO Trans"},{"key":"10.1016\/j.clinthera.2017.12.008_bib16","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clinthera.2017.12.008_bib17","first-page":"5448","article-title":"Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice","volume":"49","author":"Nagy","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinthera.2017.12.008_bib18","doi-asserted-by":"crossref","first-page":"H1862","DOI":"10.1152\/ajpheart.01320.2005","article-title":"Distributed model of peritoneal fluid absorption","volume":"291","author":"Stachowska-Pietka","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.clinthera.2017.12.008_bib19","first-page":"1","article-title":"Theoretical and experimental bases of intraperitoneal chemotherapy","volume":"12","author":"Dedrick","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clinthera.2017.12.008_bib20","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/1097-0142(197711)40:5<2375::AID-CNCR2820400554>3.0.CO;2-3","article-title":"A quantitative measurement of peritoneal drainage in malignant ascites","volume":"40","author":"Bronskill","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2017.12.008_bib21","first-page":"342","article-title":"Peritoneal reactions to particulate matter in peritoneal dialysis solutions","volume":"21","author":"Lasker","year":"1975","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/j.clinthera.2017.12.008_bib22","first-page":"2641","article-title":"Determinants of tumor blood flow: a review","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinthera.2017.12.008_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/0006-291X(91)91752-X","article-title":"Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor)","volume":"179","author":"Yeo","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinthera.2017.12.008_bib24","first-page":"2631","article-title":"Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation","volume":"53","author":"Nagy","year":"1993","journal-title":"Cancer Res"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817311141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817311141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T12:06:07Z","timestamp":1751198767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817311141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0149291817311141"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.12.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}